Cancer Genetics, Inc. (CGI) is a leader in enabling precision medicine in oncology from bench to bedside through the use of oncology biomarkers and molecular testing. CGI has a global footprint with state-of-the-art facilities in the US (NJ, NC & CA), India and China. The Company offers a comprehensive range of unique diagnostic tests and laboratory services to support biomarker and companion diagnostics discovery, development and commercialization. Our reference labs are CLIA-certified and CAP-accredited in the US and have licensure from several states including New York State.

CGI actively supports biopharma companies with both genomic-based, and comprehensive biomarker testing services in critical disease areas. CGI’s network of key opinion leaders and collaborations with leading hospitals and medical centers allows CGI to offer our biopharma partners not only high quality testing with quick turnaround times, but also innovation and patient insights.